Biopôle Investment Programme (BIP)

About

A 24-month programme for life sciences start-ups located on the Biopôle campus, combining up to CHF 90,000 in non-dilutive funding, investor-readiness training and investor exposure, with a conditional CHF 250,000 Pre-Clinical Top-Up.

Benefits

• 💰Up to CHF 90,000 non-dilutive funding
  Up to CHF 90,000 in non-dilutive, no-strings-attached funding that can support rent, R&D, consulting or salaries
• 🧭Investment Advisory Board guidance
  Programme applicants receive constructive feedback from the Investment Advisory Board, and Biopôle SA follows up with participants throughout the programme
• 📊Investor-style due diligence training
  Participating companies receive an investor-style business investigation and establish a real data room to evaluate whether venture documentation is robust enough
• 🤝Investor exposure
  Regular investor panels provide exposure, insights and opportunities to connect with top-tier investors in Biopôle’s network
• 💵Pre-Clinical Top-Up
  Conditional on at least CHF 250,000 in external funding after Investment Training, start-ups facing high clinical validation costs may receive an extra CHF 250,000 as a convertible loan, bringing total support to at least CHF 500,000, plus support to recruit a key C-level fractional executive

Eligibility Criteria

• Mandatory: the applicant must be a start-up located on the Biopôle campus
• Mandatory: the applicant must be active in life sciences
• Target profile: high-potential life sciences start-up on the Biopôle campus
• Pre-Clinical Top-Up: available following Investment Training to start-ups facing high clinical validation costs
• Pre-Clinical Top-Up: requires at least CHF 250,000 in external funding

Participation Commitments

• Apply through the Biopôle website
• Participating start-ups join a 24-month programme
• Participants undergo Investment Training, including due diligence simulations and documentation reviews
• Applications are assessed and participants selected by the Investment Advisory Board
• Winter-session application deadline is 10 November 2026 and the jury date is 1 December
• Pre-Clinical Top-Up applicants must have completed Investment Training and raised at least CHF 250,000 in external capital

Target Sector

Healthcare & Life Sciences

Target Location

Start-ups must be located on the Biopôle campus in Epalinges/Lausanne, Switzerland.